Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Heart Rhythm
|
February 8, 2018
Calcium/calmodulin-dependent protein kinase II regulation of I<sub>Ks</sub> during sustained β-adrenergic receptor stimulation
Tyler Shugg, Derrick E Johnson, Minghai Shao, et al.
Cardiovascular Drugs and Therapy
|
November 16, 2019
Association of Regulatory Genetic Variants for Protein Kinase Cα with Mortality and Drug Efficacy in Patients with Heart Failure
Jasmine A Luzum, Christopher Ting, Edward L Peterson, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
January 13, 2025
Factors Associated With the Recovery of Left Ventricular Ejection Fraction in Patients With Anthracycline-Induced Left Ventricular Dysfunction
Tyler Shugg, Tk Nguyen, Xuesi Hua, et al.
Journal of Cardiovascular Electrophysiology
|
June 24, 2016
Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers
Ahmed M Abdelhady, Tyler Shugg, Nancy Thong, et al.
Pediatric Pulmonology
|
October 28, 2025
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
Tyler Shugg, Katherine A Gallaway, Nick Powell, et al.
Drug Design, Development and Therapy
|
May 21, 2026
Population Pharmacokinetics and Model-Informed Precision Dosing of Lenalidomide Incorporating Total and Unbound Plasma Concentrations in Renally Impaired Patients with Multiple Myeloma
Hyeonji Kim, Sung-Soo Park, Suein Choi, et al.
Clinical Pharmacology and Therapeutics
|
March 7, 2026
Pharmacokinetic Drug-Drug Interaction Potential of Oral Anticancer Drugs
Fatimah Alhurayri, Islam R Younis, Shadia I Jalal, et al.
Clinical Pharmacology and Therapeutics
|
January 10, 2025
Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs
Hyunwoo Koo, Tayler B Smith, John T Callaghan, et al.
Frontiers in Cardiovascular Medicine
|
January 2, 2023
Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer
Elizabeth J Rowe, Tyler Shugg, Reynold C Ly, et al.
JCO Precision Oncology
|
February 24, 2022
Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers
Tyler Shugg, Reynold C Ly, Elizabeth J Rowe, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Heart Rhythm
|
February 8, 2018
Calcium/calmodulin-dependent protein kinase II regulation of I<sub>Ks</sub> during sustained β-adrenergic receptor stimulation
Tyler Shugg, Derrick E Johnson, Minghai Shao, et al.
Cardiovascular Drugs and Therapy
|
November 16, 2019
Association of Regulatory Genetic Variants for Protein Kinase Cα with Mortality and Drug Efficacy in Patients with Heart Failure
Jasmine A Luzum, Christopher Ting, Edward L Peterson, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
January 13, 2025
Factors Associated With the Recovery of Left Ventricular Ejection Fraction in Patients With Anthracycline-Induced Left Ventricular Dysfunction
Tyler Shugg, Tk Nguyen, Xuesi Hua, et al.
Journal of Cardiovascular Electrophysiology
|
June 24, 2016
Efavirenz Inhibits the Human Ether-A-Go-Go Related Current (hERG) and Induces QT Interval Prolongation in CYP2B6*6*6 Allele Carriers
Ahmed M Abdelhady, Tyler Shugg, Nancy Thong, et al.
Pediatric Pulmonology
|
October 28, 2025
Enrichment of Germline Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Pathogenic Variants in Patients With Solid Tumors: Evidence for Increased Cancer Risk
Tyler Shugg, Katherine A Gallaway, Nick Powell, et al.
Drug Design, Development and Therapy
|
May 21, 2026
Population Pharmacokinetics and Model-Informed Precision Dosing of Lenalidomide Incorporating Total and Unbound Plasma Concentrations in Renally Impaired Patients with Multiple Myeloma
Hyeonji Kim, Sung-Soo Park, Suein Choi, et al.
Clinical Pharmacology and Therapeutics
|
March 7, 2026
Pharmacokinetic Drug-Drug Interaction Potential of Oral Anticancer Drugs
Fatimah Alhurayri, Islam R Younis, Shadia I Jalal, et al.
Clinical Pharmacology and Therapeutics
|
January 10, 2025
Return of Clinically Actionable Pharmacogenetic Results From Molecular Tumor Board DNA Sequencing Data: Workflow and Estimated Costs
Hyunwoo Koo, Tayler B Smith, John T Callaghan, et al.
Frontiers in Cardiovascular Medicine
|
January 2, 2023
Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer
Elizabeth J Rowe, Tyler Shugg, Reynold C Ly, et al.
JCO Precision Oncology
|
February 24, 2022
Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers
Tyler Shugg, Reynold C Ly, Elizabeth J Rowe, et al.
Page
of 4